InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+5.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Burzik Catherine M, Director. Director active across 4 companies, notably Orthofix Medical Inc.. In total, 16 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €44k. History available since 21 June 2021. The latest transaction was filed on 28 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Burzik Catherine M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
930 shares0Common StockSEC:0001062993-25-001305:0
47,486 shares@ US$14.2387.6% of flowCommon StockSEC:0000950170-24-043032:0
923 shares0Common StockSEC:0001062993-24-001292:0
900 shares0Common StockSEC:0001062993-24-001295:0
120,676 shares0Common StockSEC:0001209191-23-052978:0
3,589 shares0Common StockSEC:0001209191-23-038789:0
14,354 shares0Common StockSEC:0001209191-23-008138:0
848 shares0Common StockSEC:0001062993-23-001429:0
14,052 shares0Common StockSEC:0001209191-23-002645:0
2,730 sharesCommon StockSEC:0001127602-22-020696:0
8,844 shares0Common StockSEC:0001209191-22-035049:0
820 shares0Common StockSEC:0001062993-22-001643:0
1,660 shares@ US$30.276.6% of flowCommon StockSEC:0001209191-21-065776:0
Canonical exit: 17 Feb 2022 (T+90)
3,077 sharesCommon StockSEC:0001127602-21-023391:0
5,976 shares0Common StockSEC:0001209191-21-042755:0
1,267 sharesCommon StockSEC:0001543407-16-000089:0
16 of 16 declarations
About Burzik Catherine M
BURZIK CATHERINE M is Administrateur at Orthofix Medical Inc., Becton Dickinson & Co and HAEMONETICS CORP. She has 16 filings in total, and among the recent filings tracked, buys amount to EUR 44200 and sells to EUR 0, over the period from 2016-01-29 to 2025-01-30, with the modal transaction nature listed as Attribution.
